Editas Medicine, Inc. — Director's Dealing 2020

Jul 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2020-07-15

Reporting Person: Albright Charles (EVP/Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-15	Common Stock	S	3000	$32.22	Disposed	28373	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020.